Flexion Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference

Rhea-AI Summary

Flexion Therapeutics (Nasdaq:FLXN) announced that CEO Michael Clayman will participate in a fireside chat at the 29th Annual Credit Suisse Virtual Healthcare Conference.

The event is set for November 11, 2020, starting at 8:45 a.m. ET. Investors can access the live webcast through Flexion's website. Flexion Therapeutics specializes in developing novel therapies for musculoskeletal conditions, especially osteoarthritis.

News Market Reaction – FLXN

-7.16%

-7.16% Session move

In the trading session that priced this news, FLXN declined 7.16%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BURLINGTON, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the 29^th Annual Credit Suisse Virtual Healthcare Conference. The virtual fireside chat is scheduled to begin at 8:45 a.m. ET on Wednesday, November 11, 2020.

To access the live webcast of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com.

About Flexion Therapeutics
Flexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun. Visit flexiontherapeutics.com.

Contact:

Scott Young
Vice President, Corporate Communications & Investor Relations
Flexion Therapeutics, Inc.
T: 781-305-7194
syoung@flexiontherapeutics.com

FAQ

When is Michael Clayman's fireside chat at the Credit Suisse Virtual Healthcare Conference?

Michael Clayman's fireside chat is scheduled for November 11, 2020, at 8:45 a.m. ET.

How can I access the webcast of the Flexion Therapeutics presentation?

You can access the live webcast of the presentation on Flexion's official website.

What is the focus of Flexion Therapeutics?

Flexion Therapeutics focuses on developing novel local therapies for musculoskeletal conditions, particularly for osteoarthritis.

What is the stock symbol for Flexion Therapeutics?

The stock symbol for Flexion Therapeutics is FLXN.

Who is participating in the Credit Suisse Virtual Healthcare Conference?

Michael Clayman, M.D., President and CEO of Flexion Therapeutics, will participate in the conference.